Robert R. Ruffolo

Insider Reports History

Signature
/s/ Marc Panoff, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert R. Ruffolo:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LB PHARMACEUTICALS INC Director Stock Option (Right to Buy) 22.4K Sep 10, 2025 Direct
Aridis Pharmaceuticals, Inc. Director Restricted Stock Units 10K Dec 5, 2022 Direct
Elicio Therapeutics, Inc. Director Stock Option (Right to Buy) 7.9K May 19, 2025 Direct
LB PHARMACEUTICALS INC Director Common Stock 2.37K Sep 10, 2025 Direct
Sigilon Therapeutics, Inc. Director Stock Option (Right to Buy) 0 $6.64 Aug 11, 2023 Direct

Insider Reports Filed by Robert R. Ruffolo

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LBRX LB PHARMACEUTICALS INC Sep 10, 2025 7 $0 4 Sep 12, 2025 Director
LBRX LB PHARMACEUTICALS INC Sep 10, 2025 0 $0 3 Sep 10, 2025 Director
ELTX Elicio Therapeutics, Inc. May 19, 2025 1 $0 4 May 20, 2025 Director
ELTX Elicio Therapeutics, Inc. Nov 21, 2024 1 $0 4 Nov 25, 2024 Director
ELTX Elicio Therapeutics, Inc. Dec 28, 2023 1 $0 4 Dec 29, 2023 Director
SGTX Sigilon Therapeutics, Inc. Aug 11, 2023 3 -$36.1K 4 Aug 11, 2023 Director
ELTX Elicio Therapeutics, Inc. Jun 1, 2023 0 $0 3 Jun 7, 2023 Director
SGTX Sigilon Therapeutics, Inc. May 19, 2023 1 $0 4 May 22, 2023 Director
ARDS Aridis Pharmaceuticals, Inc. Dec 5, 2022 1 $0 4 Dec 7, 2022 Director
SGTX Sigilon Therapeutics, Inc. May 26, 2022 1 $0 4 May 27, 2022 Director
ARDS Aridis Pharmaceuticals, Inc. Oct 4, 2021 1 $0 4 Oct 5, 2021 Director
SGTX Sigilon Therapeutics, Inc. Jul 1, 2021 3 -$66.1K 4 Jul 2, 2021 Director
SGTX Sigilon Therapeutics, Inc. Jun 24, 2021 1 $88.6K 4 Jun 28, 2021 Director